Enzymes with phosphotriesterase and lactonase activities in Archaea

Current Chemical Biology

Volumn 2, Issue 3, 2008, Pages 237-248

  Merone, Luigia ^a   Mandrich, Luigi ^a   Rossi, Mosè ^a   Manco, Giuseppe ^a  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

Archaea; Decontamination; Lactonase; Organophosphates; Thermostable phosphotriesterase

Indexed keywords

ACETYLCHOLINESTERASE; BACTERIAL PROTEIN; CARBOXYLESTERASE; GLUCONOLACTONASE; ORGANOPHOSPHATE; PHOSPHOTRIESTERASE; PROTEIN SACPOX; PROTEIN SSOPOX; UNCLASSIFIED DRUG;

ARCHAEBACTERIUM; BIOLOGICAL MODEL; BREVUNDIMONAS DIMINUTA; CATALYSIS; CELL COMMUNICATION; CHEMICAL STRUCTURE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME KINETICS; ENZYME STABILITY; ENZYME SUBSTRATE; GENE EXPRESSION; GENE IDENTIFICATION; MOLECULAR EVOLUTION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SULFOLOBUS ACIDOCALDARIUS; SULFOLOBUS SOLFATARICUS; THERMOSTABILITY;

BACTERIA (MICROORGANISMS); BREVUNDIMONAS DIMINUTA; EUKARYOTA; SULFOLOBUS ACIDOCALDARIUS; SULFOLOBUS SOLFATARICUS;

EID: 54749096000     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231308785739756     Document Type: Review

References (96)

1. Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto, Japan. Lancet 1995; 346: 290-3.
2. Ohbu S, Yamashina A, Takasu N, et al. Sarin Poisoning on Tokyo subway (obtained from the web site: http://www.sma.org.) South Med J 1997; 90: 587-95.
3. Brown MA, Brix KA. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 1998; 6: 393-408.
4. Aldridge WN, Reiner E. Acylated amino acids in inhibited B-esterases. In: Neuberger, A, Tatum E.L. Eds, Enzyme Inhibitors as Substrates. North-Holland, Amsterdam: North Holland 1972; 170-5.
5. WHO, World Health Organization, 1986b. World Health Organization Metabolism and mode of action. Organophosphorus Insecticides: a General Introduction. WHO, Geneva, 39-48.
6. WHO, World Health Organization, 1986c. Effects of organophosphorus insecticides on the nervous system. World Health Organization. Organophosphorus Insecticides: a General Introduction. WHO, Geneva, 58-69.
7. Sogorb MA, Vilanova E. Enzymes involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis. Toxicol Lett 2002; 128: 215-28. Review.
8. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit Rev Toxicol 1991; 21: 465-87. Review.
9. Gupta RC. Toxicology of Organophosphate and Carbamate Compounds. Academic Press Inc., US 2005.
10. Wei Y, Wang J, Tang CT, Wang W. A study of organic solvent component in the emulsion system for decontamination of polymer-thickened chemical warfare agents. J Disp Sci Technol 1996; 17: 307-19.
11. Sogorb MA, Vilanova E, Carrera V. Future applications of phosphotriesterases in the prophylaxis and treatment of organophosporus insecticide and nerve agent poisonings. Toxicol Lett 2004; 151: 219-33. Review.
12. Dumas DP, Caldwell SR, Wild JR, Raushel FM. Purification and properties of the phosphotriesterase from Pseudomonas diminuta. J Biol Chem 1989; 264: 9659-66.
13. Dumas DP, Durst HD, Landis WG, Raushel FM, Wild JR. Inactivation of organophosphorus nerve agents by the phosphotriesterase from Pseudomonas diminuta. Arch Biochem Biophys 1990; 277: 155-9.
14. Griffiths AD, Tawfik DS. Directed evolution of an extremely fast phosphotriesterase by in vitro compartmentalization. EMBO J 2003; 22: 24-35.
15. Benning MM, Shim H, Raushel FM, Holden HM. High-resolution X ray structures of different metal-substituted forms of phosphotriesterase from Pseudomonas diminuta. Biochemistry 2001; 40: 2712-22.
16. Shim H, Raushel FM. Self-assembly of the binuclear center of phosphotriesterase. Biochemistry 2000; 39: 7357-64.
17. Caldwell SR, Newcomb JR, Schlecht KA, Raushel FM. Limits of diffusion in the hydrolysis of substrates by the phosphotriesterase from Pseudomonas diminuta. Biochemistry 1991; 30: 7438-44.
18. Lewis VE, Donarski WJ, Wild JR, Raushel FM. Mechanism and stereochemical course at phosphorus of the reaction catalyzed by a bacterial phosphotriesterase. Biochemistry 1988; 27: 1591-7.
19. Benning MM, Hong SB, Raushel FM, Holden HM. The binding of substrate analogs to phosphotriesterase. J Biol Chem 2000; 275: 30556-60.
20. Aubert SD, Li Y, Raushel FM. Mechanism for the hydrolysis of organophosphates by the bacterial phosphotriesterase. Biochemistry 2004; 43: 5707-15.
21. Donarski WJ, Dumas DP, Heitmeyer DH, Lewis VE, Raushel FM. Structure-activity relationships in the hydrolysis substrates by the phosphotriesterase from Pseudomonas diminuta. Biochemistry 1989; 28: 4650-5.
22. Roodvelt C, Tawfik DS. Shared promiscuous activities and evolutionary features in various members of amidohydrolase superfamily. Biochemistry 2005; 44: 12728-36.
23. Buchbinder JL, Stephenson RC, Dresser MJ, Pitera JW, Scanlan TS, Fletterick RJ. Biochemical characterization and crystallographic structure of an Escherichia coli protein from the phosphotriesterase gene family. Biochemistry 1998; 37: 5096-5106.
24. Cheng TC, DeFrank JJ, Rastogi VK. Alteromonas prolidase for organophosphorus G-agent decontamination. Chem Biol Interact 1999; 14; 119-120: 455-62.
25. Zheng J, Constantine CA, Zhao L, et al. Molecular Interaction between Organophosphorus Acid Anhydrolase and Diisopropylfluorophosphate. Biomacromolecules 2005; 6: 1555-60.
26. Létant SE, Kane SR, Hart BR, et al. Hydrolysis of acetylcholinesterase inhibitors-organophosphorus acid anhydrolase enzyme immobilization on photoluminescent porous silicon platforms. Chem Commun (Camb) 2005; 21: 851-3.
27. Scharff EI, Koepke J, Fritzsch G, Lucke C, Ruterjans H. Crystal structure of diisopropylfluorophosphatase from Loligo vulgaris. Structure 2001; 9: 493-502.
28. Blum MM, Löhr F, Richardt A, Rüterjans H, Chen JC. Binding of a designed substrate analogue to diisopropyl fluorophosphatase: implications for the phosphotriesterase mechanism. J Am Chem Soc 2006; 128: 12750-7.
29. Mackness B, Durrington PN, Mackness MI. The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 2000; 13: 357-363.
30. Sampson MJ, Braschi S, Willis G, Astley SB. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes. Clin Sci (Lond) 2005, 109: 189-97.
31. Harel M, Brumshtein B, Meged R, et al. 3-D structure of serum paraoxonase 1 sheds light on its activity, stability, solubility and crystallizability. Arh Hig Rada Toksikol 2007; 58: 347-53.
32. Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 78-88. Review.
33. Aharoni A, Gaidukov L, Yagur S, Toker L, Silman I, Tawfik DS. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc Natl Acad Sci USA 2004; 101: 482-7.
34. Yeung DT, Josse D, Nicholson JD, et al. Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model. Biochim Biophys Acta 2004; 1702: 67-77.
35. La Du BN, Aviram M, Billecke S, et al. On the physiological role(s) of the paraoxonases. Chem Biol Interact 1999; 119-120: 379-88. Review.
36. Khersonsky O, Tawfik DS. Structure-Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase. Biochemistry 2005; 44: 6371-82.
37. Aharoni A, Gaidukov L, Khersonsky O, Mc QGS, Roodveldt C, Tawfik DS. The 'evolvability' of promiscuous protein functions. Nat Genet 2005; 37: 73-6.
38. Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 2005; 46: 1239-47.
39. Tateda K, Ishii Y, Kimura S, Horikawa M, Miyairi S, Yamaguchi K. Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery? J Infect Chemother 2007; 13: 357-67.
40. Merone L, Mandrich L, Rossi M, Manco G. A thermostable phosphotriesterase from the archaeon Sulfolobus solfataricus: cloning, overexpression and properties. Extremophiles 2005; 9: 297-305.
41. Porzio E, Merone L, Mandrich L, Rossi M, Manco G. A new phosphotriesterase from Sulfolobus acidocaldarius and its comparison with the homologue from Sulfolobus solfataricus. Biochimie 2007; 89: 625-36.
42. She Q, Singh RK, Confalonieri F, et al. The complete genome of the crenarchaeon Sulfolobus solfataricus P2. Proc Natl Acad Sci USA 2001; 98: 7835-40.
43. Chen-Goodspeed M, Sogorb MA, Wu F, Hong SB, Raushel FM. Structural determinants of the substrate and stereochemical specificity of phosphotriesterase. Biochemistry 2001; 40: 1325-31.
44. Siddavattam D, Khajamohiddin S, Manavathi B, Pakala SB, MerrickM Transposon-like organization of the plasmid borne organophosphate degradation (opd) gene cluster found in Flavobacterium sp. Appl Environ Microbiol 2003; 69: 2533-9.
45. Horne I, Qiu X, Russell RJ, Oakeshott JG. The phosphotriesterase gene opdA in Agrobacterium radiobacter P230 is transposable. FEMS Microbiol Lett 2003; 222: 1-8.
46. Hou X, Maser RL, Magenheimer BS, Calvet JP. A mouse kidney- and liver-expressed cDNA having homology with a prokaryotic parathion hydrolase (phosphotriesterase)-encoding gene: abnormal expression in injured and polycystic kidneys. Gene 1996; 168: 157-63.
47. Brown KA. Phosphotriesterases of Flavobacterium sp. Soil Biol Biochem 1980; 12: 105-12.
48. Afriat L, Roodveldt C, Manco G, Tawfik DS. The Latent Promiscuity of Newly Identified Microbial Lactonases Is Linked to a Recently Diverged Phosphotriesterase. Biochemistry 2006; 45: 13677-86.
49. Manco G, Merone L, Mandrich L, Rossi M. A new phosphotriesterase cloned from the archaeon Sulfolobus solfataricus MT4, in: Proceedings of the first Japanese Conference on Extremophiles, 2005, Available from: .
50. Vanhooke JL, Benning MM, Raushel FM, Holden HM. Three-dimensional structure of the zinc-containing phosphotriesterase with the bound substrate analog diethyl 4-methylbenzylphosphonate. Biochemistry 1996; 35: 6020-5.
51. Seibert CM, Raushel FM. Structural and catalytic diversity within the amidohydrolase superfamily, Biochemistry 2005; 44: 6383-91.
52. Elias M, Dupuy J, Merone L. Crystallization and preliminary X-ray diffraction analysis of the hyperthermophilic Sulfolobus solfataricus phosphotriesterase. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007; 63: 553-5.
53. Holm L, Sander C. An evolutionary treasure: unification of a broad set of amidohydrolases related to urease. Proteins 1997; 28: 72-8.
54. Jabri E, Carr MB, Hausinger RP, Karplus PA. The crystal structure of urease from Klibsiella aerogenes. Science 1995; 268: 998-1004.
55. Thoden JB, Phillips GN, Neal TM, Raushel FM, Holden HM. Molecular structure of dihydroorotase: a paradigm for catalysis through the use of a binuclear metal center. Biochemistry 2001; 40: 6989-97.
56. Ghanem E, Raushel FM. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase Toxicol Appl Pharmacol 2005; 207: 459-70. Review.
57. Hong SB, Raushel FM Stereochemical constraints on the substrate specificity of phosphotriesterase. Biochemistry 1999; 38: 1159-65.
58. Raushel FM. Bacterial detoxification of organophosphate nerve agents. Curr Opin Microbiol 2002; 5: 288-95.
59. Yang H, Carr PD, McLoughlin SY, et al. Evolution of an organophosphate-degrading enzyme: a comparison of natural and direct evolution. Protein Eng 2003; 16: 135-45.
60. Benning MM, Kuo JM, Raushel FM, Holden HM Three dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry 1994; 33: 15001-7.
61. Fuqua C, Parsek MR, Greenberg EP. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu Rev Genet 2001; 35: 439-68. Review.
62. Miller B, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 2001; 55: 165-99. Review.
63. Whitehead ND, Barnard AML, Slater H, Simpson NJL, Salmond GPC. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev 2001; 25: 365-404.
64. Welch, M, Todd DE, Whitehead NA, McGowan SJ, Bycroft, BW, Salmond GPC. N-acyl homoserine lactone binding to the CarR receptor determines quorum-sensing specificity in Erwinia. EMBO J 2000; 19: 631-41.
65. Zhang L, Murphy PJ, Kerr A, Tate ME. Agrobacterium conjugation and gene regulation by N-acyl-L-homoserine lactones. Nature 1993; 362: 446-8.
66. Dong YH, Xu JL, Li XZ, Zhang LH. AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc Natl Acad Sci USA 2000; 97: 3526-31.
67. Zhang HB, Wang LH, Zhang, LH. Genetic control of quorumsensing signal turnover in Agrobacterium tumefaciens. Proc Natl Acad Sci USA 2002; 99: 4638-43.
68. Oosterban RA, Janz HS. In: Florkin M, Stotz EH (eds) Comprehensive. Biochemistry 1965; vol. 16. Elsevier, Amsterdam pp 1-54
69. Bencharit S, Morton CL, Xue Y, Potter PM, Redinbo MR. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nat Struct Biol 2003; 10: 349-56.
70. Millard CB, Lockridge O, Broomfield CA. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase. Biochemistry 1998; 37: 237-47.
71. Harel M, Aharoni A, Gaidukov L, et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 2004; 11: 412-19.
72. Uroz S, Chhabra SR, Camara M, Williams P, Oger P, Dessaux Y. N-Acylhomoserine lactone quorum-sensing molecules are modified and degraded by Rhodococcus erythropolis W2 by both amidolytic and novel oxidoreductase activities. Microbiology 2005; 151: 3313-22.
73. Paggi RA, Martone CB, Fuqua C, De Castro RE. Detection of quorum sensing signals in the haloalkaliphilic archaeon Natronococcus occultus. FEMS Microbiol Lett 2003; 221: 49-52.
74. O'Brien PJ, Herschlag D. Catalytic promiscuity and the evolution of new enzymatic activities, Chem Biol 1999; 6: 91-105.
75. Bornscheuer UT, Kazlauskas RJ. Catalytic promiscuity in biocatalysis: Using old enzymes to form new bonds and follow new pathways. Angew Chem Int Ed 2004; 43: 6032-40.
76. Matsumura I, Ellington AD. In vitro evolution of â-glucuronidase into a â-galactosidase proceeds through nonspecific intermediates. J Mol Biol 2001; 305: 331-9.
77. Cheng T, Calomiris JJ. A cloned bacterial enzyme for nerve agent decontamination. Enz Microb Tech 1996; 18: 597-601.
78. DeFrank JJ. Organophosphorus cholinesterase inhibitors: detoxification by Microbial Enzymes. In Applications of Enzyme Biotechnology, ed. JW Kelly TO Baldwin 1991; 165-80.
79. Grimsley JK, Rastogi VK, Wild JR. Biological detoxification of organophosphorus neurotoxins. In Bioremediation: Principles and Practice ed. Sikdar SK, Irvine RL 1997; 577-614.
80. Russell AJ, Berberich JA, Drevon GF, Koepsel RR. Biomaterials for mediation of chemical and biological warfare agents. Annu Rev Biomed Eng 2003; 5: 1-27. Review.
81. Rochu D, Viguie N, Renault F, Crouzier D, Froment MT, Masson P. Contribution of the active site metal cation to catalytic activity and to conformational stability of phosphotriesterase: a thermo- and pH-dependence study, Biochem J 2004; 380: 627-33.
82. Caldwell SR, Raushel FM. Detoxification of organophosphate pesticides using an immobilized phosphotriesterase from Pseudomonas diminuta. Biotechnol Bioeng 1991; 37: 103-9.
83. Caldwell SR, Raushel FM. Detoxification of organophosphate pesticides using a nylon based immobilized phosphotriesterase from Pseudomonas diminuta. Appl Biochem Biotech 1991; 31: 59-63.
84. Grimsley JK, Singh WP, Wild JR, Giletto A. A novel, enzyme-based method for thewound-surface removal and decontamination of organophosphorous nerve agents. In Bioactive Fibers and Polymers ed. Edwards JV, Vigo TL. ACS Symp Ser 742 2001; 35-49.
85. Gill I, Ballesteros A. Bioencapsulation within synthetic polymers (part 2): non-sol-gel protein-polymer composites. TIBTech 2000; 18: 469-79.
86. Braatz JA. Biocompatible polyurethane-based hydrogels. J Biomater Appl 1994; 9: 71-96.
87. LeJeune KE, Mesiano AJ, Bower SB, Grimsley JK, Wild JR, Russell AJ. Dramatically stabilised phosphotriesterase polymers for nerve agent degradation. Biotech Bioeng 1997; 54: 105-14.
88. Richins RD, Mulchandani A, Chen W. Expression, immobilization and enzymatic characterisation of cellulose-binding domain-organophosphate hydrolase fusion enzymes. Biotechnol Bioeng 2000; 69: 591-6.
89. Chaize B, Winterhalter M, Fournier D. Encapsulation of proteins in pre-formed liposomes. Biotechniques 2003; 34: 1-3.
90. Mulchandani P, Chen W, Mulchandani A, Wang J, Chen L. Amperometric microbial biosensor for direct determination of organophosphate pesticides using recombinant microorganism with surface expressed organophosphorus hydrolase. Biosens Bioelectron 2001 16: 433-7.
91. Bloom JD, Wilke CO, Arnold FH, Adami C. Stability and the evolvability of function in a model protein. Biophys J 2004; 86: 2758-64.
92. Bloom JD, Labthavikul ST, Otey CR, Arnold FH. Protein stability promotes evolvability. Proc Natl Acad Sci USA 2006; 103: 5869-74.
93. Hecky J, Muller KM. Structural perturbation and compensation by directed evolution at physiological temperature leads to thermostabilization of beta-lactamase. Biochemistry 2005; 44: 12640-54.
94. Giver L, Gershenson A, Freskgard PO, Arnold FH. Directed evolution of a thermostable esterase.Proc Natl Acad Sci USA 1998; 95: 12809-13.
95. Cherry JR, Lamsa MH, Schneider P, Vind J, Svendsen A, Jones A, Pedersen AH. Directed evolution of a fungal peroxidase. Nat Biotechnol 1999; 17: 379-84.
96. Acharya P, Rajakumara E, Sankaranarayanan R, Rao NM. Structural basis of selection and thermostability of laboratory evolved Bacillus subtilis lipase. J Mol Biol 2004; 341: 1271-81.